Executive Brief — CMC Data Infrastructure

CMC readiness stalls when data stays trapped in silos.

Method transfers, comparability studies, and regulatory packages all require data from multiple disconnected systems. Scientists spend weeks manually reconstructing lineage that should have been preserved from the start — and every new program compounds the gap.

Get the Executive Brief Explore the Architecture

CMC Data Infrastructure — The Numbers

12–18 mo

Typical tech transfer timeline, site-to-site (ISPE, 2018)

Weeks

Average method transfer cycle per site pair (industry benchmark)

3–5

Systems per comparability study (LIMS, ELN, CDS, instruments, stability)

Manual

Lineage reconstruction for regulatory packages

77%

Expect AI Within 2 Years — Lack the Data Foundation (Pistoia Alliance, 2024)

Trusted by 6 of the 10 largest pharmaceutical companies in the world

And leading biotechs and agrochemical companies

6 of 10

Top-10 Pharma Companies

150+

Vendors

400+

Instrument Models

100+

Analytical Techniques

The CMC Bottleneck

Every Process Change, Method Transfer, and Filing Depends on Disconnected Data

12–18 mo Tech transfer timelines across sites (ISPE, 2018) — each requiring manual reconciliation of data from incompatible systems

Manual Lineage reconstruction — scientists assembling comparability data from LIMS, ELN, CDS, and instrument systems separately

Repeated Every regulatory package requires the same data collection, reconciliation, and verification work from scratch

0% Compounding — method validations, stability protocols, and instrument qualifications are rebuilt per site, not reused

What You Get

Three Deliverables, Custom to Your CMC Organization

CMC Data Dependency Map

Your method transfer, comparability, and regulatory workflows mapped across the four principles. See which data dependencies are manual and which can be governed.

Regulatory Readiness Assessment

Gap analysis for 21 CFR Part 11, ICH Q2 (International Council for Harmonisation) method validation, and ICH Q5E comparability. See where your data lineage meets regulatory requirements and where it falls short.

CMC Infrastructure Roadmap

Phased deployment plan from governed instrument data through cross-program intelligence. Each phase shows expected time savings on method transfers, comparability studies, and regulatory filings.

“CMC is arguably the single biggest bottleneck. Every process change triggers comparability studies that depend on data scattered across a dozen systems.”

CMC Operations Lead — Top 10 Pharmaceutical Company

What the Brief Covers

Custom Analysis for Your CMC Data Infrastructure

Cross-system lineage assessment Map how data flows between LIMS (Laboratory Information Management System), ELN (Electronic Lab Notebook), CDS (Chromatography Data System), and instruments across your CMC workflows
Method transfer readiness Evaluate which method transfers carry full context and which require manual reconstruction at the receiving site
Comparability study efficiency Assess how comparability data is currently assembled and where governed lineage eliminates manual reconciliation
Regulatory package assembly Gap analysis for IND (Investigational New Drug), NDA (New Drug Application), and BLA (Biologics License Application) data packages against 21 CFR Part 11 and ICH requirements
AI readiness pathway How your governed CMC data becomes the foundation for predictive stability, AI-assisted reporting, and automated regulatory analysis

Get the CMC Data Infrastructure Executive Brief

Custom analysis for your CMC organization. We map your cross-system data dependencies, assess method transfer readiness, and deliver a roadmap to governed data infrastructure for regulatory-grade packages.